The sources behind our pages
Every medical statement on this site rests on published research or professional guidance, checked by a surgeon. These are the sources, grouped by topic, with a line on what each one supports and what kind of study it is.
How to read this list
The strongest evidence comes from guidelines, systematic reviews and randomised trials; cohort studies, case series and reviews rank below them. We say when the evidence is thin.
Every journal reference was checked against its PubMed record, and the link opens that record. Nothing here is a promise about your result: research describes groups of patients, and your surgeon assesses you personally.
Topics · 10
- Androgenetic alopecia: classification, cause, hair cycle
- Medical treatment: finasteride, minoxidil, continuing treatment after surgery
- FUE and FUT: origins, comparison, graft survival
- Implanter pens ("DHI") and sapphire blades
- Hairline design, density, follicular units, safe donor area
- Recovery and complications: shock loss, folliculitis, infection, swelling, timelines
- PRP for hair loss: positive but small trials
- Hyperbaric oxygen: wound healing, hair transplant and safety
- Afro-textured hair, beard, eyebrow, women, repair
- Medical tourism safety and choosing a clinic
Androgenetic alopecia: classification, cause, hair cycle
Male pattern baldness: classification and incidence (opens in a new tab)
Norwood OT. South Med J. 1975;68(11):1359–65. PubMed 1188424 (opens in a new tab). DOI 10.1097/00007611-197511000-00009 (opens in a new tab)
What it supports: the Norwood–Hamilton stages (I–VII) used to describe how far male hair loss has progressed, and how common each stage is by age.
cohort (classification study)
Ludwig E. Br J Dermatol. 1977;97(3):247–54. PubMed 921894 (opens in a new tab). DOI 10.1111/j.1365-2133.1977.tb15179.x (opens in a new tab)
What it supports: the three Ludwig grades of diffuse crown thinning with a preserved front hairline that are typical of women.
case series (classification)
The biology of hair follicles (opens in a new tab)
Paus R, Cotsarelis G. N Engl J Med. 1999;341(7):491–7. PubMed 10441606 (opens in a new tab). DOI 10.1056/NEJM199908123410706 (opens in a new tab)
What it supports: the anagen–catagen–telogen hair cycle and how androgens progressively shrink (miniaturise) follicles in pattern hair loss.
review
Androgenetic alopecia: a review (opens in a new tab)
Lolli F, Pallotti F, Rossi A, et al. Endocrine. 2017;57(1):9–17. PubMed 28349362 (opens in a new tab). DOI 10.1007/s12020-017-1280-y (opens in a new tab)
What it supports: how common pattern hair loss is in men and women, the role of dihydrotestosterone and inherited factors, and which treatments have evidence.
review
Medical treatment: finasteride, minoxidil, continuing treatment after surgery
Finasteride in the treatment of men with androgenetic alopecia (opens in a new tab)
Kaufman KD, Olsen EA, Whiting D, et al. J Am Acad Dermatol. 1998;39(4 Pt 1):578–89. PubMed 9777765 (opens in a new tab). DOI 10.1016/s0190-9622(98)70007-6 (opens in a new tab)
What it supports: two-year placebo-controlled trials in over 1,500 men showing daily finasteride increases hair counts and slows further loss.
RCT
Olsen EA, Dunlap FE, Funicella T, et al. J Am Acad Dermatol. 2002;47(3):377–85. PubMed 12196747 (opens in a new tab). DOI 10.1067/mjd.2002.124088 (opens in a new tab)
What it supports: 48-week trial in men showing the stronger topical minoxidil solution grows more hair than the weaker one or placebo.
RCT
Kanti V, Messenger A, Dobos G, et al. J Eur Acad Dermatol Venereol. 2018;32(1):11–22. PubMed 29178529 (opens in a new tab). DOI 10.1111/jdv.14624 (opens in a new tab)
What it supports: European guideline recommending topical minoxidil and (for men) oral finasteride, and grading the evidence for other treatments.
guideline
Gupta AK, Venkataraman M, Talukder M, Bamimore MA. JAMA Dermatol. 2022;158(3):266–274. PubMed 35107565 (opens in a new tab). DOI 10.1001/jamadermatol.2021.5743 (opens in a new tab)
What it supports: a ranking of minoxidil, finasteride and dutasteride by their effect on hair counts across randomised trials in men.
meta-analysis (network)
Effects of finasteride (1 mg) on hair transplant (opens in a new tab)
Leavitt M, Perez-Meza D, Rao NA, Barusco M, Kaufman KD, Ziering C. Dermatol Surg. 2005;31(10):1268–76. PubMed 16188178 (opens in a new tab). DOI 10.1111/j.1524-4725.2005.31202 (opens in a new tab)
What it supports: placebo-controlled trial in transplant patients in which finasteride taken before and after surgery improved hair growth around the grafts – the reason medical treatment usually continues after a transplant.
RCT
FUE and FUT: origins, comparison, graft survival
Follicular unit extraction: minimally invasive surgery for hair transplantation (opens in a new tab)
Rassman WR, Bernstein RM, McClellan R, Jones R, Worton E, Uyttendaele H. Dermatol Surg. 2002;28(8):720–8. PubMed 12174065 (opens in a new tab). DOI 10.1046/j.1524-4725.2002.01320.x (opens in a new tab)
What it supports: the paper that introduced FUE – removing follicular units one at a time with 1-mm punches instead of a strip – and a test for which patients suit it.
case series (technique description)
Follicular transplantation. Patient evaluation and surgical planning (opens in a new tab)
Bernstein RM, Rassman WR. Dermatol Surg. 1997;23(9):771–84. PubMed 9311372 (opens in a new tab).
What it supports: how strip (FUT) follicular unit transplantation is planned – assessing the donor area, estimating graft numbers and sessions.
review (technique)
Hair transplantation: Basic overview (opens in a new tab)
Jimenez F, Alam M, Vogel JE, Avram M. J Am Acad Dermatol. 2021;85(4):803–814. PubMed 33905785 (opens in a new tab). DOI 10.1016/j.jaad.2021.03.124 (opens in a new tab)
What it supports: a current overview of candidacy, FUT versus FUE, planning, expected results and timelines, written for dermatologists.
review
Review of factors affecting the growth and survival of follicular grafts (opens in a new tab)
Parsley WM, Perez-Meza D. J Cutan Aesthet Surg. 2010;3(2):69–75. PubMed 21031063 (opens in a new tab). DOI 10.4103/0974-2077.69014 (opens in a new tab)
What it supports: what affects graft survival – time out of the body, drying, temperature, storage solution and handling – and notes that claimed benefits of hyperbaric oxygen for grafts were unproven.
review
Implanter pens ("DHI") and sapphire blades
The evidence here is thin: small observational or pilot studies, and no large randomised trials. We say so on the treatment pages too.
Single hair transplantation using the Choi hair transplanter (opens in a new tab)
Choi YC, Kim JC. J Dermatol Surg Oncol. 1992;18(11):945–8. PubMed 1430550 (opens in a new tab). DOI 10.1111/j.1524-4725.1992.tb02765.x (opens in a new tab)
What it supports: the original description of the Choi implanter pen, the instrument that "DHI" procedures use to place grafts.
case series (technique description)
Lee SJ, Lee HJ, Hwang SJ, et al. Dermatol Surg. 2001;27(8):716–20. PubMed 11493294 (opens in a new tab). DOI 10.1046/j.1524-4725.2001.01029.x (opens in a new tab)
What it supports: graft survival of roughly 90–92 % at 6–12 months after implanter-pen placement; there is no forceps comparison arm.
case series
Saket K. J Maxillofac Oral Surg. 2026;25(4):1155–1165 (online 2025). PubMed 42528810 (opens in a new tab). DOI 10.1007/s12663-025-02874-w (opens in a new tab)
What it supports: a 1,000-patient observational study reporting higher graft survival with sapphire than steel blades and faster placement with double forceps – single-author, not randomised, so quote it cautiously.
cohort (observational)
Balik O. J Craniofac Surg. 2023;34(8):e803–e806. PubMed 37811982 (opens in a new tab). DOI 10.1097/SCS.0000000000009765 (opens in a new tab)
What it supports: a 12-man split-scalp study measuring blood-flow damage from a sapphire blade versus a hand-made steel slit blade – typical of the small comparisons that exist on blade material.
cohort (split-scalp)
Hairline design, density, follicular units, safe donor area
The aesthetics of follicular transplantation (opens in a new tab)
Bernstein RM, Rassman WR. Dermatol Surg. 1997;23(9):785–99. PubMed 9311373 (opens in a new tab). DOI 10.1111/j.1524-4725.1997.tb00419.x (opens in a new tab)
What it supports: why single-hair units are placed in the front rows, how density is graded across the scalp and why natural results need intact follicular units.
review (technique)
Jimenez F, Ruifernández JM. Dermatol Surg. 1999;25(4):294–8. PubMed 10417585 (opens in a new tab). DOI 10.1046/j.1524-4725.1999.08114.x (opens in a new tab)
What it supports: the measured split of follicular units into 1-, 2-, 3- and 4-hair units and a model for how much donor tissue a given graft number needs.
cohort (anatomical study)
Shapiro R. Facial Plast Surg Clin North Am. 2004;12(2):201–17. PubMed 15135130 (opens in a new tab). DOI 10.1016/j.fsc.2003.12.004 (opens in a new tab)
What it supports: hairline design principles – position, shape, deliberate irregularity and a soft transition zone of single-hair grafts.
review
Nakatsui T, Wong J, Groot D. Dermatol Surg. 2008;34(8):1016–22. PubMed 18462426 (opens in a new tab). DOI 10.1111/j.1524-4725.2008.34200.x (opens in a new tab)
What it supports: graft survival measured when grafts are planted at high ("dense packing") densities with lateral slits.
cohort (prospective count study)
Hair Transplant Practice Guidelines (opens in a new tab)
Mysore V, Kumaresan M, Garg A, et al. J Cutan Aesthet Surg. 2021;14(3):265–284. PubMed 34908769 (opens in a new tab). DOI 10.4103/JCAS.JCAS_104_20 (opens in a new tab)
What it supports: a professional-society practice guideline (India) covering candidate selection, the safe donor area and harvesting limits, graft density, and which steps must be done by the surgeon.
guideline
Follicular unit transplantation: 2005 (opens in a new tab)
Bernstein RM, Rassman WR. Dermatol Clin. 2005;23(3):393–414. PubMed 16039422 (opens in a new tab). DOI 10.1016/j.det.2005.04.002 (opens in a new tab)
What it supports: natural scalp density of about 80–120 follicular units per cm², the front planted densest with density decreasing towards the crown, and conservative densities in large sessions.
review
Hair transplantation: standard guidelines of care (opens in a new tab)
Patwardhan N, Mysore V; IADVL Dermatosurgery Task Force. Indian J Dermatol Venereol Leprol. 2008;74 Suppl:S46–53. PubMed 18688103 (opens in a new tab).
What it supports: the only society guideline sentence that gives a planting density: a minimum of 35–45 units per cm².
guideline
Logic of hair transplantation (opens in a new tab)
Venkataram A, Mysore V. J Cutan Aesthet Surg. 2018;11(4):169–172. PubMed 30886469 (opens in a new tab). DOI 10.4103/JCAS.JCAS_183_18 (opens in a new tab)
What it supports: up to half the hair can be lost before thinning shows, 35–40 grafts per cm² is an adequate planting density, and a plan can be estimated as area multiplied by density; curly and long hair cover more.
review (symposium)
Recipient area (opens in a new tab)
Marwah MK, Mysore V. J Cutan Aesthet Surg. 2018;11(4):202–210. PubMed 30886474 (opens in a new tab). DOI 10.4103/JCAS.JCAS_124_18 (opens in a new tab)
What it supports: planting densities zone by zone (a transition zone of 20–30 per cm², a central tuft of 40–45, about 35 across the frontal zone) and the warning that more than 60 per cm² can harm the scalp’s blood supply.
review (symposium)
Dense packing: surgical indications and technical considerations (opens in a new tab)
Farjo B, Farjo N. Facial Plast Surg Clin North Am. 2013;21(3):431–436. PubMed 24017984 (opens in a new tab). DOI 10.1016/j.fsc.2013.06.004 (opens in a new tab)
What it supports: "dense packing" means more than 30–35 grafts per cm² in one operation; it is not achievable in coarse or curly hair and needs enough donor hair and stable hair loss.
review
Recovery and complications: shock loss, folliculitis, infection, swelling, timelines
Surgical complications in hair transplantation: a series of 533 procedures (opens in a new tab)
Salanitri S, Gonçalves AJ, Helene A Jr, Lopes FH. Aesthet Surg J. 2009;29(1):72–6. PubMed 19233009 (opens in a new tab). DOI 10.1016/j.asj.2008.11.005 (opens in a new tab)
What it supports: an overall complication rate of about 4.7 % in 533 procedures, mostly minor (folliculitis, widened donor scars), with necrosis rare.
case series
Complications in Hair Transplantation (opens in a new tab)
Kerure AS, Patwardhan N. J Cutan Aesthet Surg. 2018;11(4):182–189. PubMed 30886471 (opens in a new tab). DOI 10.4103/JCAS.JCAS_125_18 (opens in a new tab)
What it supports: the range of donor- and recipient-area complications – bleeding, infection, folliculitis, swelling, shock loss, over-harvesting – and how they are prevented.
review
Complications of Hair Transplant Procedures—Causes and Management (opens in a new tab)
Garg AK, Garg S. Indian J Plast Surg. 2021;54(4):477–482. PubMed 34984088 (opens in a new tab). DOI 10.1055/s-0041-1739255 (opens in a new tab)
What it supports: post-operative shedding ("shock loss") of existing hair around 3–4 weeks with regrowth after about 3–4 months, plus the causes of swelling, folliculitis and infection.
review
Hair transplant (opens in a new tab)
NHS. nhs.uk, Cosmetic procedures. Page reviewed 29 September 2023 (next review September 2026).
What it supports: a plain-language timeline – grafts fragile for the first two weeks, transplanted hair sheds in the first weeks, new growth at about four months, full result at 10–18 months – plus risks and how to check a surgeon.
patient information
PRP for hair loss: positive but small trials
The meta-analyses pool small trials and disagree on how certain the benefit is. "Mixed evidence" is the honest summary.
Gupta AK, Carviel JL. J Dermatolog Treat. 2017;28(1):55–58. PubMed 27152474 (opens in a new tab). DOI 10.1080/09546634.2016.1179712 (opens in a new tab)
What it supports: pooled early trials found PRP increased hair density versus control, but from few, small studies.
meta-analysis
Evans AG, Mwangi JM, Pope RW, et al. J Dermatolog Treat. 2022;33(1):498–511. PubMed 32410524 (opens in a new tab). DOI 10.1080/09546634.2020.1770171 (opens in a new tab)
What it supports: a larger pooled analysis showing an increase in hair density with PRP, with wide variation between preparations and protocols.
meta-analysis
Dervishi G, Liu H, Peternel S, Labeit A, Peinemann F. J Cosmet Dermatol. 2020;19(4):827–835. PubMed 31452328 (opens in a new tab). DOI 10.1111/jocd.13113 (opens in a new tab)
What it supports: the trial evidence for PRP in pattern hair loss was judged limited and of low certainty, so benefit remains uncertain.
systematic review
Hyperbaric oxygen: wound healing, hair transplant and safety
Hospital guidelines accept hyperbaric oxygen for hard-to-heal wounds and compromised grafts. For hair transplant patients there is one small randomised study, and the wellness claims rest on thin evidence: not enough to promise anything.
Mathieu D, Marroni A, Kot J. Diving Hyperb Med. 2017;47(1):24–32. PubMed 28357821 (opens in a new tab). DOI 10.28920/dhm47.1.24-32 (opens in a new tab)
What it supports: the European list of accepted and non-accepted uses of hyperbaric oxygen: compromised skin grafts and flaps, diabetic foot lesions and radiation injury are on it; autism, multiple sclerosis and stroke are recommended against.
consensus
A European Code of Good Practice for Hyperbaric Oxygen Therapy: Review 2022 (opens in a new tab)
Kot J, Desola J, Lind F, Mueller P, Jansen E, Burman F. Diving Hyperb Med. 2023;53(4 Suppl):1–17. PubMed 38092370 (opens in a new tab). DOI 10.28920/dhm53.4.suppl.1-17 (opens in a new tab)
What it supports: what counts as hyperbaric oxygen therapy (oxygen above 1.5 atmospheres for at least an hour), the two chamber types, assessment by a hyperbaric physician before treatment, and the fire-safety rules on what may enter a chamber.
consensus
Hyperbaric oxygen therapy for chronic wounds (opens in a new tab)
Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S. Cochrane Database Syst Rev. 2015;(6):CD004123. PubMed 26106870 (opens in a new tab). DOI 10.1002/14651858.CD004123.pub4 (opens in a new tab)
What it supports: in 12 trials, diabetic foot ulcers healed more often at six weeks with hyperbaric oxygen but not at one year, with low confidence in the evidence.
systematic review (Cochrane)
Hyperbaric oxygen therapy for treating acute surgical and traumatic wounds (opens in a new tab)
Eskes A, Vermeulen H, Lucas C, Ubbink DT. Cochrane Database Syst Rev. 2013;(12):CD008059. PubMed 24343585 (opens in a new tab). DOI 10.1002/14651858.CD008059.pub3 (opens in a new tab)
What it supports: there is too little good evidence to say whether HBOT helps acute surgical wounds heal.
systematic review (Cochrane)
Fan ZX, Gan Y, Qu Q, et al. J Cosmet Dermatol. 2021;20(3):917–921. PubMed 32770782 (opens in a new tab). DOI 10.1111/jocd.13665 (opens in a new tab)
What it supports: a small randomised study (34 patients) in which HBOT after transplant reduced itching, folliculitis and early shedding, but graft survival at nine months was no different.
RCT (small)
Parnis J, Magrin AMF, Hassan H. J Cosmet Dermatol. 2024;23(6):1940–1955. PubMed 38356446 (opens in a new tab). DOI 10.1111/jocd.16228 (opens in a new tab)
What it supports: 17 studies of hyperbaric oxygen in aesthetic practice, all at high risk of bias; the evidence is conflicting, and the hair transplant trial above is the strongest of them.
review
Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified (opens in a new tab)
Heyboer M 3rd, Sharma D, Santiago W, McCulloch N. Adv Wound Care (New Rochelle). 2017;6(6):210–224. PubMed 28616361 (opens in a new tab). DOI 10.1089/wound.2016.0718 (opens in a new tab)
What it supports: how often each side effect occurs, from ear barotrauma and temporary short-sightedness to the rare oxygen-toxicity seizure, and an untreated collapsed lung as the absolute contraindication.
review
Huang X, Wang R, Zhang Z, Wang G, Gao B. Front Physiol. 2021;12:791872. PubMed 34887780 (opens in a new tab). DOI 10.3389/fphys.2021.791872 (opens in a new tab)
What it supports: pooled trials found no significant effect of hyperbaric oxygen before or after exercise on performance or recovery.
meta-analysis
Joint position statement on the use of "mild hyperbaric therapies" in humans (opens in a new tab)
European Committee for Hyperbaric Medicine, European Underwater and Baromedical Society. ECHM and EUBS, 20 December 2022.
What it supports: Europe’s hyperbaric societies strongly advise against promoting low-pressure "mild" chambers for wellness, energy or rejuvenation.
position statement
Unauthorized soft-shelled hyperbaric chambers may pose serious health risks (opens in a new tab)
Health Canada. Public advisory RA-82214, 16 June 2026.
What it supports: no soft-shelled chamber is authorised in Canada; the risks include fire, infection and damage to the ears, sinuses, lungs and teeth.
advisory (regulator)
Hyperbaric Oxygen Therapy: Get the Facts (opens in a new tab)
US Food and Drug Administration. Consumer update bulletin, 26 July 2021.
What it supports: hyperbaric oxygen is cleared for a limited list of conditions and is promoted for uses the FDA has not cleared; patients should use an accredited facility.
advisory (regulator)
Afro-textured hair, beard, eyebrow, women, repair
Umar S. Plast Reconstr Surg Glob Open. 2016;4(9):e1069. PubMed 27757365 (opens in a new tab). DOI 10.1097/GOX.0000000000001069 (opens in a new tab)
What it supports: standard rotary punches transect tightly curled hair at high rates, and a curved non-rotary punch brought transection below 5 % in 18 patients.
case series
Beard Hair Transplantation (opens in a new tab)
Bared A. Facial Plast Surg Clin North Am. 2020;28(2):237–241. PubMed 32312510 (opens in a new tab). DOI 10.1016/j.fsc.2020.01.010 (opens in a new tab)
What it supports: planning, donor choice, angles and density for beard transplants.
review
Eyebrow and Eyelash Hair Transplantation: A Systematic Review (opens in a new tab)
Klingbeil KD, Fertig R. J Clin Aesthet Dermatol. 2018;11(6):21–30. PubMed 29942421 (opens in a new tab).
What it supports: the published eyebrow (and eyelash) transplant series – techniques, donor sites and reported outcomes.
systematic review
Female hair restoration (opens in a new tab)
Unger RH. Facial Plast Surg Clin North Am. 2013;21(3):407–17. PubMed 24017982 (opens in a new tab). DOI 10.1016/j.fsc.2013.05.011 (opens in a new tab)
What it supports: how female pattern hair loss differs, which women are candidates, and how hairline and density planning change.
review
The art of repair in surgical hair restoration part I: basic repair strategies (opens in a new tab)
Bernstein RM, Rassman WR, Rashid N, Shiell RC. Dermatol Surg. 2002;28(9):783–94. PubMed 12269870 (opens in a new tab). DOI 10.1046/j.1524-4725.2002.02030.x (opens in a new tab)
What it supports: strategies for correcting earlier poor transplants – removing or redistributing "pluggy" grafts, camouflage and donor-scar revision.
review (with cases)
Medical tourism safety and choosing a clinic
ISHRS Position Statement on Qualifications for Scalp Surgery (opens in a new tab)
International Society of Hair Restoration Surgery. Revised by the Board of Governors 13 July 2024.
What it supports: any incision of the scalp is surgery that must be performed by a licensed, trained physician, including operating FUE punches and robotic devices.
position statement
What is a Black Market Clinic in Hair Restoration (opens in a new tab)
ISHRS "Fight the FIGHT" patient campaign. What is a Black Market Clinic in Hair Restoration?
What it supports: the definition of "black market" clinics (technicians operating with little or no physician involvement) and their risks – over-harvested donor areas, poor results, misleading advertising.
patient information
Cosmetic surgery abroad (opens in a new tab)
NHS. nhs.uk, Cosmetic procedures. Page reviewed 14 December 2022.
What it supports: a checklist for surgery abroad – consult the surgeon, ask about follow-up and complications, check insurance, and rest before flying home.
patient information
Complications of Medical Tourism in Aesthetic Surgery: A Systematic Review (opens in a new tab)
Alkaelani MT, Koussayer B, Blount T, et al. Ann Plast Surg. 2023;91(6):668–673. PubMed 37962261 (opens in a new tab). DOI 10.1097/SAP.0000000000003683 (opens in a new tab)
What it supports: across 44 studies of aesthetic surgery abroad, infection was the most common complication and often appeared after the patient had returned home; it covers aesthetic surgery in general, not hair transplants specifically.
systematic review
Where these sources are used
Hair transplantPatient guidesFAQGlossaryNew research we’re reading
Found a mistake, or a better source? Write to us and we will check it. Contact
Research describes groups. Your plan is about you.
For your own plan, send four photos: our lead surgeon replies with your plan, a graft estimate and the full price, usually within 24 hours. Free, and you are not committing to anything.
Like any surgery, a hair transplant has risks. They include infection, scarring, shock loss and grafts that grow poorly. Read about the risks